Haemostatic effects of low osmolar non-ionic and ionic contrast media: A double-blind comparative study

British Journal of Radiology

Volumn 73, Issue 867, 2000, Pages 248-255

  Hoffmann, J J M L ^a   Tielbeek, A V ^a   Krause, W ^b  

^a CATHARINA HOSPITAL   (Netherlands)

^b BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPLASMIN; BETA THROMBOGLOBULIN; FIBRIN; FIBRINOGEN; IOPROMIDE; IOXAGLIC ACID; LEUKOCYTE ELASTASE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; PLASMINOGEN ACTIVATOR INHIBITOR; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; AGED; ANTICOAGULATION; ARTERIOGRAPHY; ARTICLE; BLOOD AND HEMOPOIETIC SYSTEM; BLOOD CELL COUNT; CLINICAL TRIAL; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG INHIBITION; FEMALE; FIBRINOLYSIS; HUMAN; HUMAN CELL; MALE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION; THROMBOSIS;

EID: 0034030423     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr.73.867.10817039     Document Type: Article

References (30)

1. Dawson P. The clotting issue: etiologic factors in thromboembolism I. Chemistry, pharmacology, and toxicology of angiographic contrast agents. Invest Radiol 1993;28(Suppl. 5):S25-30.
2. Dawson P, Cousins C, Bradshaw A. The clotting issue: etiologic factors in thromboembolism II. Clinical considerations. Invest Radiol 1993;28 (Suppl. 5):S31-6.
3. Hoffmeister HM, Heller W. Radiographic contrast media and the coagulation and complement systems. Invest Radiol 1996;31:591-5.
4. Fareed J, Moncada R, Messmore HL, Walenga JM, Hoppensteadt D, Wehrmacher WH. Molecular markers of contrast media-induced adverse reactions. Semin Thromb Hemost 1984;10:306-28.
5. Stormorken H, Skalpe IO, Testart MC. Effects of various contrast media on coagulation, fibrinolysis and platelet function. An in vitro and in vivo study. Invest Radiol 1986;21:348-54.
6. Ing JJ, Smith DC, Bull BS. Differing mechanisms of clotting inhibition by ionic and non-ionic contrast agents. Radiology 1989;172:345-8.
7. Belleville J, Freyria AM, Pinet A, Cornillon B, Paul J, Clendinnen G, et al. Contrast agents used for excretory urography impair platelet function in human patients. Thromb Res 1982;28:533-44.
8. Raininko R, Ylinen SL. Effect of ionic and non-ionic contrast media on aggregation of red blood cells in vitro. Acta Radiol 1987;28:87-92.
9. Aspelin P, Schmid-Schonbein H, Malotta H. Do non-ionic contrast media increase red cell aggregation and clot formation? Invest Radiol 1988;23 (Suppl. 2):S326-33.
10. Grabowski E, Head C, Michelson AD. Non-ionic contrast media. Procoagulants or clotting innocents? Invest Radiol 1993;28(Suppl. 5):S21-4.
11. Stormorken H, Sakariassen KS. Contrast media effects on hemostatic and thrombotic parameters. Possible consequences for practical techniques and prophylactic measures. Acta Radiol 1995;36(Suppl. 399):173-81.
12. Robertson HJF. Blood clot formation in angiographic syringes containing non-ionic contrast media. Radiology 1987;163:621-2.
13. Kopko PM, Smith DC, Bull BS. Thrombin generation in nonclottable mixtures of blood and non-ionic contrast agents. Radiology 1990;174:459-61.
14. Grines CL, Schreiber TL, Savas V, Jones DE, Zidor FJ, Gangadharan V, et al. A randomised trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1996;27: 1381-6.
15. Jespersen J, Bertina RM, Haverkate F, editors. ECAT assay procedures, a manual of laboratory techniques. Dordrecht: Kluwer Academic Publishers, 1992.
16. Matrai A, Whittington RB, Ernst E. A simple method for estimating whole blood viscosity at standardised hematocrit. Clin Hemorheol 1987;7: 261-5.
17. Krause W, Schuhmann-Giampieri G, Staks Th, Kaufmann J. Dose proportionality of Iopromide: pharmacokinetics and tolerability after iv injection in healthy volunteers. Eur Radiol 1994;46:339-43.
18. Albanese JR, Venditto JA, Patel GC, Ambrose JA. Effects of ionic and non-ionic contrast media on in vitro and in vivo platelet activation. Am J Cardiol 1995;76:1059-63.
19. Hwang MH, Piao ZE, Murdock DK, Messmore HL, Giardina JJ, Scanlon PJ. Risk of thromboembolism during diagnostic and interventional cardiac procedures with non-ionic contrast media. Radiology 1990;174:453-7.
20. Brogan WC, Hillis LD, Lange RA. Contrast agents for cardiac catheterization: conceptions and misconceptions. Am Heart J 1991;122:1129-35.
21. Cousins C, Dutka DP, Bradshaw A, Dawson P. Effect of arterial cannulation and contrast agents on blood coagulation. Acad Radiol 1995;2:663-6.
22. Biancardi M, Cimminiello C, Toschi V, Schiarina G, Regalia F, Casolo F, et al. TAT, F1+2 and D-dimer levels in patients after coronary angiography with nonionic or ionic contrast media or after cardiac catheterization. Sem Thromb Hemost 1996; 22(Suppl. 1):61-5.
23. Mukherjee M, Scully MF, Thomas M, Jewitt D, Kakkar VV. The potential thrombogenic action of a non-ionic radiographic contrast medium used during coronary angiography is offset by heparin during coronary angioplasty. Thromb Haemost 1996;76:679-81.
24. Riemann CD, Massey CV, McCarron DL, Borkowski P, Johnson PC, Ziskind AA. Ionic contrast agent-mediated endothelial injury causes increased platelet deposition to vascular surfaces. Am Heart J 1993;125:71-8.
25. Wiesel M-L, Zupan M, Wolff F, Grunebaum L, Brechenmacher C, Cazenave J-P. Potential thrombogenicity of angiographic contrast agents. Thromb Res 1991;64:291-4.
26. Fareed J, Moncada R, Messmore HL, Walenga JM, Hoppensteadt D, Wehrmacher WH. Molecular markers of contrast media-induced adverse reactions. Semin Thromb Hemost 1984;10:306-28.
27. Corot C, Chronos N, Sabattier V. In vitro comparison of the effects of contrast media on coagulation and platelet activation. Blood Coag Fibrinol 1996;7:602-8.
28. Parvez Z, Moncada R, Fareed J, Messmore HL. Antiplatelet action of intravascular contrast media. Implications in diagnostic procedures. Invest Radiol 1984;19:208-11.
29. Schmid-Schönbein H, Teitel P, Tietz G, Özlen A. Hämorheologische Effekte von loxaglat: ein Beitrag zur Deutung der Wirkung hyperosmolarer Röntgenkontrastmittel auf die Fließfähigkeit von Erythrozyten. Radiologe 1984;24:478-87.
30. Hoffmann J, Bonnier J, Bartholomeus I. Hemorheological effects of a non-ionic contrast medium: an ex vivo study. Clin Hemorheol 1992; 12:217-21.